InsidersTradesSigma
Track the 东富龙 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 东富龙 has recorded 2 insider filings. Market capitalisation: €9.3bn. The latest transaction was disclosed on 29 December 2023 (Purchase). Among the most active insiders: 郑效东. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
东富龙是一家在XSHE市场上市的健康和制药公司。它专注于创新医药产品的开发和制造。